PierreFrancoisDequin retweeted
Very proud to have presented results of the Amikinhal trial today. Thank you to all investigators, clinical research assistants, nurses, patients and families for this collective success.
Presented at #LIVES2023:
In a randomized trial involving critically ill patients who had undergone mechanical ventilation for 3 days, a 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia.
Full AMIKINHAL trial results: nej.md/472lySJ
PierreFrancoisDequin retweeted
🥁🤩 Please retweet. Super happy to announce the @Inserm workshop "METHODS IN META-RESEARCH: HOW TO IMPROVE RESEARCH PRACTICE" organised by @IsabelleBoutron, me, and Philippe Ravaud with a stellar team of speakers: J Ioannidis, @Maclomaclee @dirnagl Carl Moons, Roland Roberts...
PierreFrancoisDequin retweeted
Les membres de mon #labo de #recherche et moi-même sommes ravis d'annoncer qu'à l'issue d'une phase d'#auditions et d'#évaluations rigoureuses, le #CEPR sera labelisé et soutenu 5 ans de plus par l' @Inserm et @UnivTours.
De plus, dès 01/2024, le labo passera de 3 à 4 #équipes
Ou de gourmet? (Le féminin gourmette ne donne pas trop bien, si?) Bref: 🤤
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
PierreFrancoisDequin retweeted
Félicitations à Katalin Karikó et Drew Weissman qui reçoivent le Prix Nobel de Médecine 2023 pour leur travaux de recherche ayant contribué au développement au vaccin à ARN messager contre la COVID-19
#PrixNobel #PrixNobel2023
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
old concepts are too often repeated like mantras without their validity being questioned
Talking about a revolution...
Do we have do re-write nephrological textbooks?
@MarcusSaemann @AKronbichler @kidney_boy @hswapnil @doc_ecmo @dguerrot
Severe Hyponatremia Correction, Mortality, and Central Pontine Myelinolysis | NEJM Evidence evidence.nejm.org/doi/full/1…
👋🏻👋🏻👋🏻 Laurent and your Team!
I am extremely honored that the BAT-VTE trial, an academic therapeutic trial led by @INNOVTE1, emerged victorious in the international Dragon's Den competition. 🏆
Huge thanks to the jury and @INVENT_VTE for their support!
We must find how to keep the balance💚
Il illustre mes cours de semio, celui-là…
This Post is from an account that no longer exists. Learn more
👋🏻👋🏻👋🏻
Fier d'annoncer que le premier patient a été inclus dans l'essai #BAT-VTE, essai Thérapeutique académique financé par le PHRC, et réalisé au sein du réseau @INNOVTE1
@MedvascC @ChuSaintEtienne
@Sainbiose_Lab
PierreFrancoisDequin retweeted
Raising concerns on questionable ethics approvals – a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection | Research Integrity and Peer Review | Full Text researchintegrityjournal.bio…
PierreFrancoisDequin retweeted
Mise à jour majeure de notre site web
👉 sfpt-fr.org/vie-de-la-sfpt/c…
PierreFrancoisDequin retweeted
[Guide des villes 2023]
Decouvrez sans plus tarder notre guide des villes pour vous orienter au mieux dans votre choix ! Vous y trouverez aussi les contacts des differentes subdivisions !
anjmir.org/guide-des-villes/
@CeMIR_off @La_SRLF
PierreFrancoisDequin retweeted
‘Zombie’ trials had the semblance of real research, but closer scrutiny showed they were actually hollow shells, masquerading as reliable information.
@NaudetFlorian
nature.com/articles/d41586-0…
